BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25223786)

  • 41. Transducin-like enhancer protein 1 mediates estrogen receptor binding and transcriptional activity in breast cancer cells.
    Holmes KA; Hurtado A; Brown GD; Launchbury R; Ross-Innes CS; Hadfield J; Odom DT; Carroll JS
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2748-53. PubMed ID: 21536917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The transcriptional co-repressor TLE3 regulates myogenic differentiation by repressing the activity of the MyoD transcription factor.
    Kokabu S; Nakatomi C; Matsubara T; Ono Y; Addison WN; Lowery JW; Urata M; Hudnall AM; Hitomi S; Nakatomi M; Sato T; Osawa K; Yoda T; Rosen V; Jimi E
    J Biol Chem; 2017 Aug; 292(31):12885-12894. PubMed ID: 28607151
    [TBL] [Abstract][Full Text] [Related]  

  • 43. KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function.
    Gala K; Li Q; Sinha A; Razavi P; Dorso M; Sanchez-Vega F; Chung YR; Hendrickson R; Hsieh JJ; Berger M; Schultz N; Pastore A; Abdel-Wahab O; Chandarlapaty S
    Oncogene; 2018 Aug; 37(34):4692-4710. PubMed ID: 29755131
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recruitment of histone deacetylase 4 to the N-terminal region of estrogen receptor alpha.
    Leong H; Sloan JR; Nash PD; Greene GL
    Mol Endocrinol; 2005 Dec; 19(12):2930-42. PubMed ID: 16051668
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TLE3 Sustains Luminal Breast Cancer Lineage Fidelity to Suppress Metastasis.
    Anstine LJ; Majmudar PR; Aponte A; Singh S; Zhao R; Weber-Bonk KL; Abdul-Karim FW; Valentine M; Seachrist DD; Grennel-Nickelson KE; Cuellar-Vite L; Sizemore GM; Sizemore ST; Webb BM; Thompson CL; Keri RA
    Cancer Res; 2023 Apr; 83(7):997-1015. PubMed ID: 36696357
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.
    Laganière J; Deblois G; Giguère V
    Mol Endocrinol; 2005 Jun; 19(6):1584-92. PubMed ID: 15831516
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
    Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
    BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
    Lu W; Katzenellenbogen BS
    Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuroprotective effects of a chromatin modifier on ischemia/reperfusion neurons: implication of its regulation of BCL2 transactivation by ERα signaling.
    Guo J; Zhang T; Yu J; Li HZ; Zhao C; Qiu J; Zhao B; Zhao J; Li W; Zhao TZ
    Cell Tissue Res; 2016 Jun; 364(3):475-488. PubMed ID: 26728277
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gender matters: estrogen receptor alpha (ERα) and histone deacetylase (HDAC) 1 and 2 control the gender-specific transcriptional regulation of human uridine diphosphate glucuronosyltransferases genes (UGT1A).
    Kalthoff S; Winkler A; Freiberg N; Manns MP; Strassburg CP
    J Hepatol; 2013 Oct; 59(4):797-804. PubMed ID: 23714156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suppressive effect of aryl hydrocarbon receptor repressor on transcriptional activity of estrogen receptor alpha by protein-protein interaction in stably and transiently expressing cell lines.
    Kanno Y; Takane Y; Takizawa Y; Inouye Y
    Mol Cell Endocrinol; 2008 Sep; 291(1-2):87-94. PubMed ID: 18565642
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estradiol regulates corticotropin-releasing hormone gene (crh) expression in a rapid and phasic manner that parallels estrogen receptor-alpha and -beta recruitment to a 3',5'-cyclic adenosine 5'-monophosphate regulatory region of the proximal crh promoter.
    Lalmansingh AS; Uht RM
    Endocrinology; 2008 Jan; 149(1):346-57. PubMed ID: 17947358
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
    Gougelet A; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TLE3 is a dual-function transcriptional coregulator of adipogenesis.
    Villanueva CJ; Waki H; Godio C; Nielsen R; Chou WL; Vargas L; Wroblewski K; Schmedt C; Chao LC; Boyadjian R; Mandrup S; Hevener A; Saez E; Tontonoz P
    Cell Metab; 2011 Apr; 13(4):413-427. PubMed ID: 21459326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Flightless I (Drosophila) homolog facilitates chromatin accessibility of the estrogen receptor α target genes in MCF-7 breast cancer cells.
    Jeong KW
    Biochem Biophys Res Commun; 2014 Apr; 446(2):608-13. PubMed ID: 24632205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.
    Zhang H; Xie X; Zhu X; Zhu J; Hao C; Lu Q; Ding L; Liu Y; Zhou L; Liu Y; Huang C; Wen C; Ye Q
    J Biol Chem; 2005 Dec; 280(52):43188-97. PubMed ID: 16219765
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of TLE3 by bone marrow stromal cells is regulated by canonical Wnt signaling.
    Kokabu S; Sato T; Ohte S; Enoki Y; Okubo M; Hayashi N; Nojima J; Tsukamoto S; Fukushima Y; Sakata Y; Katagiri T; Rosen V; Yoda T
    FEBS Lett; 2014 Feb; 588(4):614-9. PubMed ID: 24444608
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6.
    Yamaguchi N; Nakayama Y; Yamaguchi N
    J Biol Chem; 2017 May; 292(20):8136-8148. PubMed ID: 28270510
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel estrogen receptor alpha-associated protein, template-activating factor Ibeta, inhibits acetylation and transactivation.
    Loven MA; Muster N; Yates JR; Nardulli AM
    Mol Endocrinol; 2003 Jan; 17(1):67-78. PubMed ID: 12511607
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Widespread enhancer activation via ERα mediates estrogen response in vivo during uterine development.
    Jefferson WN; Kinyamu HK; Wang T; Miranda AX; Padilla-Banks E; Suen AA; Williams CJ
    Nucleic Acids Res; 2018 Jun; 46(11):5487-5503. PubMed ID: 29648668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.